REFERENCES
- Amazcua JL, O'Grady J, Salmon JA, Moncada S. Prolonged paradoxial effect of aspirin on platelet behavior and bleeding time in man. Thromb Res 1979; 16: 69–79.
- Amrein PC, Ellman L, Harris WH. Aspirin-induced prolongation of bleeding time and perioperative blood loss. JAMA 1981; 245: 1825–1828.
- Angelini GD, Newby AC. The future of saphenous vein as a coronary artery bypass conduit. Eur Heart J 1989; 10: 273–280.
- Baume P. Aspirin is good for you. Med J Aust 1992; 157: 511–513.
- Baume PE, Shaw J, Donnan G, et al. Evidence now clear that aspirin will reduce heart and stroke deaths. Aust Dr Weekly 1992; 7: 19.
- Briggs TP, Parker C, Anson K, Miller RA. Hemostasis in urology: mechanism and pharmacology. Br J Urol 1992; 70: 225–229.
- Burch JW, Stanford N, Majerus PW. Inhibition of prostaglandin synthetasis by oral aspirin. J Clin Invest 1978; 61: 314–319.
- Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299: 53–59.
- Ciavarella D. Transfusion-associated hepatitis and AIDS. N Engl J Med 1988; 318: 184.
- Editorial. Desmopressin and arterial thrombosis. Lancet 1989; 29: 938.
- Faunø P, Petersen KD, Husted SE. Increased blood loss after peroperative NSAID. Acta Orthop Scand 1993; 64: 552–524.
- Ferraris VA, Gildengorin V. Predictors of excessive blood use after coronary artery bypass grafting. A multivariate analysis. J Thorac Cardiovasc Surg 1989; 98: 492–494.
- Flordal PA, Sahlin S. Use of desmopressin to prevent bleeding complications in patients treated with aspirin. Br J Surg 1993; 80: 723–724.
- Gavriliuk AI. Fibrinolytic hemorrhages in patients with prostatic adenomas treated with acetyl salicylate in the pre-operative period. Vrach delo 1987; 1: 96–98.
- Gay WA. Aspirin blood loss and transfusion. Ann Thorac Surg 1990; 50: 345.
- Godal HC, Eika C, Dybdahl JH, et al. Aspirin and bleeding time. Lancet 1979; 1: 1236.
- Goldman S, Copeland J, Moritz T, et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a veterans administration cooperative study. Circulation 1988; 77: 1324–1332.
- Goldman S, Copeland J, Moritz T, et al. Saphenous vein graft patency one year after coronary artery bypass surgery and effect of antiplatelet therapy: results of a veterans administration cooperative study. Circulation 1989; 80: 1190–1197.
- Harris WH, Salzman EW, Athanasoulis CA, Waltman AC, Desanctis RW. Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med 1977; 297: 1246–1248.
- Hensler MK, Madsen PV. Acetylsalicylsyre-behandling efter perifer karkirurgi. Ugeskr Laeger 1994; 156: 1278–1285.
- Insel PA. Analgesic-antipyretics and anti-inflamatory agents; drugs employed in the treatment of rheumatoid arthritis and gout. In: Goodman & Gilman, eds. The Pharmacological basis of therapeutics, 8th ed. New York: Pergamon Press Inc., 1990. Chapt. 26. pp. 639–645.
- Jenkins AD, Mintz PD. Optimal blood use in the genitourinary surgery. J Urol 1981; 126: 497–499.
- Jorgensen KA, Dyerberg J, Schou OA, Stoffersen E. Acetylsalicylic acid, bleeding time and age. Thromb Res 1980; 19: 799–805.
- Jorgensen KA, Olesen AS, Dyerberg J, et al. Aspirin and bleeding time: Dependency of age. Lancet 1979; 2: 302.
- Kallmann R, Nieuwenhuis HK, De Groot PG, Van Gijn J, Sixma JJ. Effects of low dose of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PG Fla excretion in healthy subjects. Thromb Res 1987; 45: 355.
- Kelsey M. The antiplatelet effect of aspirin and related component drugs on the surgical patient. J Post Anesth Nurs 1993; 8: 101–103.
- Kelton JG. Hirsh J, Carter CJ, Buchanan MR. Sex differences in the antithrombotic effect of aspirin. Blood 1978; 52: 1073–1076.
- Kennedy BM. Aspirin and surgery—a review. Ir Med J 1984; 77: 363–369.
- Kobrinsky NL, Israels ED, Gerrard JM, et al. Shortening of bleeding time by [1-deamino-8-d-arginine] vasopressin in various bleeding disorders. Lancet 1984; 1: 1145–1148.
- Leist ER. Banwell JG. Products containing aspirin. N Engl J Med 1974; 291: 710–712.
- Lewi HJE, Hales DSM, Mahmoud S, Scott R. The characteristics of post Tur blood loss: a preliminary study. Urol Red 1983; 11: 29–31.
- Mannucci PM. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988; 72: 1449–1455.
- Meier PJ, Oelz O. Aspirin as a platelet inhibitor. Pharmakritic Int 1990; 1: 1–4.
- Mielke CH, Kaneshiro MM, Maher IA, Weiner JM, Rapaport SI. The standardized normal ivy bleeding time and its prolongation by aspirin. Blood 1969; 34: 204–215.
- Milamed DR, Hedley-Whyte J. Contributions of the surgical sciences to a reduction of the mortality rate in the United States for the period 1968 to 1988. Ann Surg 1994; 219: 94–102.
- Mongin D, Ville D, Sagnard P, et al. Prevention of venous thrombosis following prostatic transurethral resection (TUR): a comparative study of acetyl-salicylic acid and calcium heparinate. Agressologie 1983; 24: 523–525.
- O'Grady J, Moncada S. Aspirin: a paradoxial effect on bleeding time. Lancet 1978; 2: 780.
- Patrignani P, Cattani P, Minuz P, Patrono C. Low dose aspirin: how low, how often. Symposium on prostaglandins and the cardiovascular system. Universitaire instelling Antwerpen Wilrijk, Belgium. 1980.
- Perkins JB, Miller HC. Blood loss during transurethral prostatectomy. J Urol 1969; 101: 93–97.
- Preston FE, Whipps S, Jackson CA, French AJ, Wyld PJ, Stoddard CJ. Inhibition of prostacyclin and platelet tromboxane A2 after low-dose aspirin. N Engl J Med 1981; 304: 76–79.
- Rajah SM, Penny A, Kester R. Aspirin and bleeding time. Lancet 1978; 2: 1104.
- Reymond MA, Marbet G, Radü EW, Gratzl O. Aspirin as a risk factor for hemorrhage in patients with head injuries. Neurosurg Rev 1992; 15: 21–25.
- Rogerson JW. Intravesical bacille Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder. Br J Urol 1994; 73: 655–658.
- Roth GJ, Stanford N, Majerus PW. Acetylation of prostaglandin synthetase by aspirin. Proc Natl Acad Sci USA 1975; 72: 3073–3076.
- Rubin RN. Aspirin and postsurgery bleeding. Ann Intern Med 1978; 89: 1006.
- Ruiz H, Saltzmann B. Aspirin-induced bilateral renal hemorrhage after extracorporeal shock wave lithotripsytherapy; implications and conclusions. J Urol 1990; 143: 791–792.
- Rutkov IM. Urological operations in the United States: 1979 to 1984. J Urol 1986; 135: 1206–1208.
- Schulman S. DDAVP—the multipotent drug in patients with coagulopathies. Transfus Med Rev 1991; V: 132–144.
- Sethi GK, Copeland JG, Goldman S, Moritz T, Zadina K, Henderson WG. Implication of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 1990; 15: 15–20.
- Seymour MA, Oesterling JE. Anterior rectal wall haematoma: Complication of transrectal ultrasound-guided biopsy of the prostate. Urol 1992; 39: 177–181.
- Silagy CA, McNeil JJ, Bulpitt CJ, Donnan GA, Tonkin AM, Worsam B. Rationale for a primary prevention study of low dose aspirin to prevent cardiovascular disease in the elderly. J Am Geriatr Soc 1991; 39: 484–491.
- Silagy CA, McNeil JJ, Donnan GA, Tonkin AM, Worsam B, Campion K. Adverse effect of low-dose aspirin in a healthy elderly population. Clin Pharmacol Ther 1993; 54: 84–89.
- Singer R. Acetylsalicylic acid, a probable cause for secondary post-tonsillectomy hemorrhage. Arch Otolaryngol 1945; 42: 19–20.
- Stage J, Jensen JH, Bonding P. Post-tonsillectomy hemorrhage and analgesics. A comparative study of acetylsalicylic acid and paracetamol. Clin Otolaryngol 1988; 13: 201–204.
- Taggart DP, Siddiqui MA, Wheatley DJ. Aspirin and blood loss. Reply to the editor. Ann Thorac Surg 1991; 51: 693–694.
- Taggart DP, Siddiqui MA, Wheatley DJ. Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. Ann Thorac Surg 1990; 50: 425–428.
- The SALT collaborative Group. Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 1991; 338: 1345–1349.
- Thurston AV, Briant S. Aspirin and post-prostatectomy hemorrhage. Br J Urol 1993; 71: 574–576.
- Torosian M, Michelsen EL, Morganroth J, MacVaugh H. Aspirin- and coumadin-related bleeding after coronary-artery bypass graft surgery. Ann Intern Med 1978; 89: 325–328.
- Violaris AG, Angelini GD. Aspirin and blood loss. Letter to the editor. Ann Thorac Surg 1991; 51: 693.
- Wallentin LC and the Research Group on Instability in Coronary Artery Disease in Southeast Sweden. Aspirin (75 mg/day) after an episode of unstable coronary artery disease: Long-term effect on the risk for myocardial infaction, occurrence of severe angina and the need for revascularization. J Am Coll Cardiol 1991; 18: 1587–1593.
- Ward JW, Holmberg SD, Allen JR, et al. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened for HIV antibody. N Engl J Med 1988; 473–478.
- Watson CJE, Deane AM, Doyle PT, Bullock KN. Identifiable factors in post-prostatectomy hemorrhage: the role of aspirin. Br J Urol 1990; 66: 85–87.
- Young VP, Giles AR, Pater J, Corbett WEN. Sex differences in bleeding time and blood loss in normal subjects following aspirin ingestion. Thromb Res 1980; 20: 705–709.